Big clinical trials may be falling to the wayside in light of a new era in health care, according to a recent Wall Street Journal report.
Personalized medicine, in which a patient’s care can essentially be customized based on genetic makeup, has signaled a shift in medical research.
Click here for more. (Paid subscription required)
